Patient Perspective on the Value of Biosimilars During IGBA #GlobalBiosimilarsWeek @accessiblemeds
Patient Perspective on the Value of Biosimilars During IGBA #GlobalBiosimilarsWeek  @accessiblemeds
Uploaded November 2022 | Updated November 2026, 3 hours ago
Steve Selde, Director of the Biosimilars Council, a division of the Association of Accessible Medicines (AAM), joins Eileen to celebrate #GlobalBiosimilarsWeek and catch up with her since she last shared her biosimilar experience.

View Eileen's story on the AAM blog: biosimilarscouncil.org/resource/singing-dancing-and-taking-care-of-herself-with-biosimilars Learn more about the annual IGBA global education initiative at globalbiosimilarsweek.org

If you are a patient, caregiver, or healthcare provider, you can also share your biosimilars story at biosimilarsresources.org/biosimilars-stories
Patient Perspective on the Value of Biosimilars During IGBA #GlobalBiosimilarsWeekGeneric Drugs Are the Prescription for Savings. Dont Take Them for Granted.The Generics and Biosimilars Industry Has a Plan to Secure Our Medicines — #SecureOurMedsMessage from CEO Dan Leonard on Access! 2021AAM All Access Promo: Mary Beth PowersGeneric Rx Drugs: Take With Confidence (Jonnie)Join Us at GRx+Biosims 2023Highlights from Craig Burton on the Newly Released 2018 Generic Drug Access & Savings ReportFDA Biosimilars Action PlanAAMs Ashlee Koonce Shares New Exhibitor Opportunities at GRx+Biosims 2019October Can Now Afford to do More to Support Her Mental HealthTotal generic and biosimilar savings to Medicare in 2021 #GRxBiosimsSavingsReport
Association for Accessible Medicines |

Patient Perspective on the Value of Biosimilars During IGBA #GlobalBiosimilarsWeek

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER